Back to top
more

Wright Medical Group N.V. (WMGI)

(Delayed Data from NSDQ)

$29.93 USD

29.93
764,757

+0.29 (0.98%)

Updated May 3, 2019 04:00 PM ET

After-Market: $29.93 (%) 5:22 PM ET

Zacks Rank:

This is our short term rating system that serves as a timeliness indicator for stocks over the next 1 to 3 months. How good is it? See rankings and related performance below.

Zacks Rank Definition Annualized Return
1Strong Buy24.15%
2Buy17.88%
3Hold9.47%
4Sell5.14%
5Strong Sell2.57%
S&P50011.11%

Zacks Rank Education - Learn about the Zacks Rank

Zacks Rank Home - Zacks Rank resources in one place

Zacks Premium - The only way to fully access the Zacks Rank

Style Scores:

The Style Scores are a complementary set of indicators to use alongside the Zacks Rank. It allows the user to better focus on the stocks that are the best fit for his or her personal trading style.

The scores are based on the trading styles of Value, Growth, and Momentum. There's also a VGM Score ('V' for Value, 'G' for Growth and 'M' for Momentum), which combines the weighted average of the individual style scores into one score.

Value Score A
Growth Score A
Momentum Score A
VGM Score A

Within each Score, stocks are graded into five groups: A, B, C, D and F. As you might remember from your school days, an A, is better than a B; a B is better than a C; a C is better than a D; and a D is better than an F.

As an investor, you want to buy stocks with the highest probability of success. That means you want to buy stocks with a Zacks Rank #1 or #2, Strong Buy or Buy, which also has a Score of an A or a B in your personal trading style.

Zacks Style Scores Education - Learn more about the Zacks Style Scores

NA Value NA Growth NA Momentum NA VGM

Industry Rank:

The Zacks Industry Rank assigns a rating to each of the 265 X (Expanded) Industries based on their average Zacks Rank.

An industry with a larger percentage of Zacks Rank #1's and #2's will have a better average Zacks Rank than one with a larger percentage of Zacks Rank #4's and #5's.

The industry with the best average Zacks Rank would be considered the top industry (1 out of 265), which would place it in the top 1% of Zacks Ranked Industries. The industry with the worst average Zacks Rank (265 out of 265) would place in the bottom 1%.

Zacks Rank Education -- Learn more about the Zacks Rank
Zacks Industry Rank Education -- Learn more about the Zacks Industry Rank

NA

Industry: NA

Zacks Premium FeatureView All Zacks #1 Ranked Stocks

Better trading starts here.

Zacks News

HealthEquity (HQY) Earnings & Revenues Beat Estimates in Q4

by Zacks Equity Research

HealthEquity (HQY) witnesses strong HSA member growth in the fourth quarter of fiscal 2019.

Allscripts Partners With Opargo to Boost Practice Management

by Zacks Equity Research

Allscripts' (MDRX) partnership with Opargo is likely to improve scheduling capabilities and practice workflows of Allscripts Practice Management solution.

Veeva Systems (VEEV) Gains From Solid Results for Fiscal Q4

by Zacks Equity Research

Veeva Systems' (VEEV) broad spectrum of products include Veeva Vault, Veeva CRM, Veeva Network and Veeva OpenData.

Stryker Buys Israel-Based OrthoSpace, Strengthens MedSurg

by Zacks Equity Research

Strong international presence and an acquisition-driven strategy are likely to fortify Stryker's (SYK) footprint in the global MedTech space.

Zacks.com featured expert Kevin Matras highlights: Columbia Sportswear, Tactile Systems Technology, Wright Medical, Carbonite and Palo Alto Networks

by Zacks Equity Research

Zacks.com featured expert Kevin Matras highlights: Columbia Sportswear, Tactile Systems Technology, Wright Medical, Carbonite and Palo Alto Networks

Allscripts Strengthens Strategic Relationship with Pulse8

by Zacks Equity Research

Pulse8 is likely to boost Allscripts' (MDRX) flagship platform Veradigm, and its existing health plan product suite that delivers pocket-friendly tools and services for health plan members.

Wright Medical Group (WMGI) Q4 Earnings and Revenues Beat Estimates

by Zacks Equity Research

Wright Medical (WMGI) delivered earnings and revenue surprises of 83.33% and 0.34%, respectively, for the quarter ended March 2019. Do the numbers hold clues to what lies ahead for the stock?

Sanghamitra Saha headshot

Play Potential Earnings Beat With These 5 Top Stocks

by Sanghamitra Saha

These top-ranked stocks are likely to beat on the bottom line in their next release.

Here's Why Investors Should Retain McKesson (MCK) Stock Now

by Zacks Equity Research

McKesson (MCK) is well positioned for growth backed by strong business plans and robust surprise trend amid cutthroat competition in the near term.

Allscripts to Fortify Middle East Foothold With New Project

by Zacks Equity Research

Qatar-based Alfardan Group and Chicago-based Northwestern Medicine select Allscripts (MDRX) for the launch of a project in the Middle East.

Here's Why Investors Should Bet on Cooper Companies (COO) Now

by Zacks Equity Research

Cooper Companies (COO) maintains its leading position in the markets of specialty lenses. Further, the company exits first-quarter fiscal 2019 on a strong note.

Here's Why Investors Should Bet on Merit Medical (MMSI) Now

by Zacks Equity Research

Merit Medical's (MMSI) upbeat guidance for 2019 is indicative of the company's brighter prospects.

    Baxter (BAX) Gets FDA Approval for Eptifibatide to Treat ACS

    by Zacks Equity Research

    Baxter's (BAX) Eptifibatide is a platelet aggregation inhibitor that prevents platelets-specialized blood cells clotting.

    Here's Why You Should Invest in AngioDynamics Stock Now

    by Zacks Equity Research

    Expanding customer base of the NanoKnife platform is likely to fortify AngioDynamics' (ANGO) foothold in the Medical Instruments space.

    Chemed Gains Ground on Solid VITAS & Roto-Rooter Businesses

    by Zacks Equity Research

    Chemed (CHE) witnesses solid revenue growth across key subsidiaries.

    Wright Medical (WMGI) Q4 Earnings & Revenues Beat Estimates

    by Zacks Equity Research

    Wright Medical's (WMGI) top-line growth in fourth-quarter 2018 can be attributed to solid performance by the Upper and the Lower Extremities segments.

    Here's Why You Should Invest in Illumina (ILMN) Stock Now

    by Zacks Equity Research

    Illumina (ILMN) continues to gain on solid international business.

    Integer Holdings' (ITGR) 2019 View Strong Despite Rivalry

    by Zacks Equity Research

    Integer Holdings (ITGR) holds a solid position in the MedTech space but is still exposed to competition.

    Masimo and Saudi Arabia MOH Collaborate for CCHD Screening

    by Zacks Equity Research

    Studies have shown that Masimo's (MASI) SET pulse oximetry can improve CCHD screening, helping to save newborns.

    Luminex Hurt By Segmental Sluggishness, Stiff Competition

    by Zacks Equity Research

    Luminex's (LMNX) dependence on its partners for revenue generation is a major problem.

    Here's Why Investors Should Buy Surmodics (SRDX) Stock Now

    by Zacks Equity Research

    Surmodics' (SRDX) solid efforts to improve its research and development stature are likely to prove beneficial in the quarters ahead.

    What's in the Cards for Genomic Health (GHDX) in Q4 Earnings?

    by Zacks Equity Research

    Genomic Health (GHDX) is expected to gain from higher Oncotype DX breast cancer test revenues in Q4.

    Can Dental Growth Drive Henry Schein's (HSIC) Q4 Earnings?

    by Zacks Equity Research

    Henry Schein (HSIC) is well placed to gain from digitalization in the global dental market.

    Here's What Will Give Shape to Medtronic's (MDT) Q3 Earnings

    by Zacks Equity Research

    Medtronic (MDT) is expected to maintain a decent market share in the core pacing backed by the continued uptake of Micra Transcatheter Pacing System in Q3.

    Here's Why Investors Should Buy CONMED (CNMD) Stock Now

    by Zacks Equity Research

    CONMED's (CNMD) guidance for 2019 buoys optimism in the stock.